SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Preliminary Results

27 Jan 2009 07:00

RNS Number : 2700M
Porvair PLC
27 January 2009
Β 

ο»Ώ

For immediate release 27Β January 2009

Β 

Preliminary results forΒ the year ended 30 November 2008

A year of growth and investment

Porvair plc (β€œPorvair”), the specialist filtration and environmental technology group, today announces its preliminary results for the year ended 30 November 2008.
Financial highlights
Β·; Revenue up 20% to Β£54.8m (2007: Β£45.5m)
Β·; Profit before tax up 23% to Β£4.2m (2007: Β£3.4m)
Β·; Earnings per share up 21% to 7.0p (2007: 5.8p)
Operating highlights
Growth
Β·; Microfiltration revenue grew 23% to Β£32.3m (2007: Β£26.2m). 11% revenue growth, excluding acquisitions, driven by strong demand from aviation and energy sectors in particular.
Β·; Metals Filtration sales grew 11% to a record $42.9m (2007: $38.6m).
Β·; Key growth projects contributed 11% of total revenue at Β£6.0m as new products began commercial sales.
Investment
Β·; Acquisitions:
Β·; Toolturn Engineering Limited acquired to support aviation and energy growth.
Β·; Seal Analytical Limited acquired to expand presence in attractive clean water markets.
Β·; Facilities:
Β·; New Microfiltration facilities opened to accommodate growth.
Β·; Capabilities:
Β·; Upgraded equipment in Metals Filtration to improve quality and reduce manufacturing labour costs.
Β·; Additional capacity installed for key growth projects set to launch in 2009.
Β·; To accommodate these investments, banking arrangements for the next three years were renewed in July 2008.

Β 

Commenting on the resultsΒ and outlook, Ben Stocks, Chief Executive, said:

"As previously reported, current trading overall is satisfactory.Β Β We are experiencing healthy demand from aviation, energy and clean water customers and this is balanced by weaker demand from US automotive and someΒ generalΒ industrialΒ segments.Β Β We are alert to the economic outlook and have addressedΒ operatingΒ costs in those parts of theΒ Group where we have seen demand soften or where we perceive a risk of weakening demand.Β Β Whilst currentΒ Sterling exchange rates inflate reported borrowings, they also helpΒ UKΒ exports andΒ improveΒ the retranslation of US dollar denominated profits.Β 

"Porvair has a very broad customer base and diversified end markets.Β Β The specialistΒ nature of our installed product base makes substitution difficult. Our filters are consumable - their use is often mandated by custom or regulation and they are usually replaced as part of a maintenance cycle.Β Β These features will give someΒ resilience in difficult times.Β Β The fact that 11% of our sales in 2008 came from new products offers good prospects for margin and market share enhancement in 2009.Β Β We are prepared for the next year or so to be more challenging, but we also see opportunities ahead and expect Porvair to be well placed for continued growth as and when markets allow."

For further information please contact:

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan Communications

0207 466 5000

Charles Ryland

Catherine Breen

Chairman and Chief Executive's statement

Overview

2008 was a year of growth and investment at Porvair, the year in which our long term new product development activities started to make a significantΒ contribution to our results.Β 

Revenues in the yearΒ ended 30 NovemberΒ 2008 were Β£54.8m, an increase of 20% on the prior year (2007:Β Β£45.5m).Β Β ProfitΒ before tax increased 23% to Β£4.2m (2007: Β£3.4m).Β Β Earnings per share increased 21% to 7.0p (2007:Β 5.8p).

New products generated revenue of Β£6.0m,Β 11% ofΒ total revenue.Β Β It is a pleasure to be able to report this to shareholders as some of these products have taken five years or more to bring to market.Β Β As we headΒ into a period of economic uncertainty it is encouraging to have a healthy roster of newly launched products in our portfolio.Β 

2008 was also a year of investment.Β Β Β£8.6m was deployed in acquiring Toolturn EngineeringΒ Limited ("Toolturn")Β and SealΒ Analytical Limited ("Seal"); moving to new facilities inΒ Fareham; generating efficiency savings in Metal Filtration and expanding capacity for new products. These investments increased net borrowings at the end of the year to Β£16.4m (2007: Β£7.0m), a figure which includes Β£2.4m attributable toΒ currency translationΒ intoΒ a weakerΒ Sterling.Β Β Three year banking facilities to accommodate these investments were put in place in July 2008.Β 

Porvair's activities and strategy

PorvairΒ specialises in filtration and related environmental technology.Β Β We operateΒ two divisions.Β Β The Microfiltration division comprises the Porvair Filtration Group,Β Porvair Sciences andΒ Seal Analytical.Β Β It serves aviation, life sciences,Β clean water, energy and otherΒ markets.Β Β The Metals Filtration division trades as SELEE CorpΒ and its primary focus isΒ moltenΒ aluminiumΒ filtration where it hasΒ aΒ global market leadership position.Β Selee also has strong market positions inΒ USΒ foundry and super-alloy filtration.Β Β 

The Group manufactures in theΒ UK,Β USAΒ andΒ GermanyΒ and sales are global.

Porvair’s strategy for the creation of growth and sustainable shareholder value is to:
Β·; Develop filtration and environmental technology positions in markets where typically:
Β·; specialist design or engineering skills win business;
Β·; regulation or quality accreditation requirements mandate product use;
Β·; consumable products are often replaced as part of a maintenance routine in order to protect more costly downstream components;
Β·; products, once designed into a specification, have very long lifecycles.
Β·; Broaden the range of products Porvair delivers to key market segments, particularly in aviation, aluminium, energy and clean water as these all have good long term growth characteristics.
Β·; Acquire complementary businesses that meet financial and commercial criteria.
Β·; Maintain an appropriately funded balance sheet and generate sufficient cash to sustain a progressive dividend policy.

Β 

Operating review

Microfiltration

The Microfiltration division performed strongly in 2008 showingΒ 11% like-for-likeΒ revenueΒ growth.Β Β TotalΒ revenueΒ including acquisitions wasΒ Β£32.3m (2007:Β Β£26.2m).Β Β Operating profits were up 16% to Β£5.1m (2007: Β£4.4m).

All keyΒ market segments performed well.Β Β Our aviation business inΒ FarehamΒ had another good year.Β Β RevenuesΒ have grown by 10% compound annually over the last five yearsΒ and having run out of space, we opened new facilities to accommodate this growth.Β Β The new plant has better clean room, manufacturing, test and laboratory facilities and gives us room for furtherΒ expansionΒ - indeed part of Seal will move into thisΒ buildingΒ in early 2009.Β Β Toolturn, a key supplier located very close to the new plant, was acquired in March to secure access to critical skills and to allow us to tender for more added-value work around the filters we design.Β Β Bringing Toolturn into the business and upgrading our facilities undoubtedly helped in signing several long term aviation contracts later in the year.Β 

2008 was a good year for energy related sales in general and gasification orders in particular.Β Β The energy order book for 2009 is healthy.Β Β Gasification continues to be a major focus of our engineering work, with sales exceeding Β£1m in 2008, although global financial issues have slowed someΒ customers'Β projects in recent months.Β Β This is not the case for nuclear programmes, several of which are accelerating in 2009Β with the order book forecasting stronger sales revenues in the second half of the coming year.Β Β 

Omnifilter, theΒ USΒ subsidiary of this division which will be renamed Porvair Filtration Group Inc in 2009, completed its first full year under our ownership with success.Β Β It grew 19% in 2008 and improvedΒ margins.

SealΒ joined the Microfiltration division in July 2008 in order to build on our presence in the clean water market.Β Β The final consideration was Β£5.6m, of which Β£4.3m was paid in cash and the remainder in Porvair shares.Β Β Seal designs and manufactures laboratory based water analysis equipment and related consumables.Β The business has a number of attractive characteristics. It operates in a well defined and growing market niche.Β Β Its highly respected products are market-leading and,Β in many applications,Β demonstrably best-in-class.Β Β Water analysis is mandatory in much of the world, and must beΒ carried out by approved methods forΒ whichΒ Seal products are ideally suited. Integration of Seal is proceeding well.Β Β We will incorporate itsΒ UKΒ operations into our existing plants in early 2009 and our strategy, which is based on re-connecting the business with its extensive installed base, is progressing well.

Metals Filtration

Metals Filtration reported record sales of $42.9m, up 11% (2007: $38.6m)Β driven by export growth, new products and price rises applied during the year to cover raw material increases. Operating profits rose to $2.0m (2007: $0.6m).

As reported at the interim stage, raw material increases early in the year were passed on successfully, albeit with a time lag as customer contract renewals came up. Margins were compressed for several months during the year, although they had largely recovered by the end of the year.

New "CSX" filters were launched in September 2008. Aluminium filtration by ceramic foam filter was invented by Selee in the 1970's, and the basic formulation, much copied around the world, has hardly changed since.Β Β Our new proprietaryΒ CSXΒ product offers superior filtration performance and much better materials handling characteristics.Β Β Initial customer trials started in 2007, and we began to get full customer qualifications during 2008.Β Β By the end of the year around 20% of our output was converted with both new and existing customers transferring.Β 

Other products that became fully commercial this year were our new nickel cobalt filters for super-alloys, which achieved full customer qualificationΒ in May; a bespoke filter forΒ use in solar panel manufacture; and a proprietary investment casting filter which is sold together with ancillary refractories. Some of these products have been in development for over five years, a period during which margins at Selee have been under pressure.Β Β The business has long had strong market positions and with these new products the Board believes that prospects for the future are good.

Two further productsΒ areΒ expectedΒ to be launched in 2009:Β 

An advanced batteryΒ component. This project follows work previously done with fuel cells. Pre-production samples are currently in customer trials and provided these are successful commercial production will start in the second quarter of 2009. Production facilities were installed during the year.Β Almost a half of the $2m costs associated were covered in the form of a prepayment from the customer, against a multi-year sales contract.Β 

A new foundry filtration product. This product isΒ currently at the customer and production trial stage. Depending on the outcome of these trials commercial sales will commence in the second quarter of 2009.

Earnings per share, dividend and financing

Earnings per share increasedΒ 21% to 7.0p (2007: 5.8p)Β per share.Β Β The Directors recommend a final dividend of 1.25p (2007: 1.20p)Β per share,Β making a full year dividend of 2.25p (2007:Β 2.20p)Β per share.Β 

Net borrowings at the year end were Β£16.4m (2007: Β£7.0m).Β Β Operating cash flow before working capital movements was Β£6.6mΒ (2007: Β£5.3m). In a year of investment two acquisitions were successfully completed and integrated at a total cash cost in the year of Β£5.1m. Β£3.5m was invested in capital expenditure, principally: Β£1.0m invested in new manufacturing facilities in Microfiltration to accommodate growth; production efficiency investments of Β£0.4m inΒ Metals Filtration, which have lowered manufacturing costs; and Β£1.6m invested in production capacity for key growth projects. Reported borrowings were further increased by Β£2.4m due to the currency translation impact of weakerΒ SterlingΒ at the year end.

Three year financing facilities wereΒ put in placeΒ in JulyΒ 2008.Β Β At 30 November 2008 the Group had Β£5.3m in cash and un-drawn facilities. Interest cover was 7 times (2007: 8 times).

Staff

On behalf of the Board we are pleased to welcomeΒ new colleagues in Toolturn and Seal, and we wish them well for the future.Β Β We have had a number of successes in Porvair in 2008.Β Β Two in particular stand out: the opening of the newΒ FarehamΒ factory without loss of customer service; and the final trials and launch of our new aluminium and NiCo filters at Selee.Β Β Our particular thanks go to the teams involved in these projects.Β Β The hard work of all our staff makes Porvair a better business every year, and we are most grateful for all their efforts.

We are sad to report that John Morgan, our former Chairman and Chief Executive, died recently. John was instrumental inΒ building Porvair. He led the management buyout of the Group in 1982 and itsΒ stock market debut in 1988. HeΒ was an enthusiastic proponent ofΒ change and oversaw the development of the business fromΒ polymerΒ products toΒ filtration and environmentalΒ technology specialists.Β Β He remained close to the businessΒ and many of its current and former staffΒ after his retirementΒ in 2006. His wise counsel and enthusiasm will be greatly missed.

Current trading and outlook

As previously reported, current trading overall is satisfactory.Β Β We are experiencing healthy demand from aviation, energy and clean water customers and this is balanced by weaker demand from US automotive and someΒ general industrialΒ segments.Β Β We are alert to the economic outlook and have addressedΒ operatingΒ costs in those parts of the group where weΒ have seenΒ demand soften or where we perceive aΒ risk of weakeningΒ demand.Β Β Whilst current Sterling exchange rates inflate reported borrowings, they also helpΒ UKΒ exports andΒ improveΒ the retranslation of US dollar denominated profits.Β 

PorvairΒ has a very broad customer base and diversified end markets.Β Β The specialistΒ nature of our installed product base makes substitution difficult.Β Β Our filters are consumable - their use is often mandated by custom or regulation and they are usually replaced as part of a maintenance cycle.Β Β These features will giveΒ someΒ resilience in difficult times.Β Β TheΒ fact that 11% of our sales in 2008 came from new products offers good prospects for margin and market share enhancement in 2009.Β Β We are prepared for the next year or so to be more challenging, but we also see opportunities ahead and expect Porvair to be well placed for continued growth as and when markets allow.

Charles MatthewsΒ - Chairman

Ben StocksΒ - Chief Executive

26 January 2009

Β Β Finance Director's review

Group operating performance

Group revenuesΒ were Β£54.8m (2007: Β£45.5m) and operating profitsΒ were Β£4.8m (2007: Β£3.8m).Β Β TheΒ operating performance of the Microfiltration andΒ Metals Filtration divisionsΒ are described inΒ detailΒ in theΒ Chairman and Chief Executive's statement. The operating lossΒ associated with the OtherΒ UnallocatedΒ segmentΒ wasΒ Β£1.3mΒ (2007: Β£0.9m), whichΒ mainly comprises Group corporate costs, some research and development costs, new business development costs and general financial services. In 2007 the Other Unallocated segmentΒ includedΒ provisions written back of Β£0.4mΒ relatedΒ to disposed businesses and property.

Key performance indicators

The Group considers its key performance indicators to be: the sales growth and operating margins of its principal operations; the profit before tax growth;Β earnings per share growth;Β interest cover,Β gearing; and return on capital employed. The table below summarises these indicators:Β 

Key performance indicators

2008

2007

Sales growth -Β Metals FiltrationΒ (US dollars)

11%

7%

Sales growth -Β Microfiltration

23%

(1)%

Operating margin -Β Group

9%

8%

Operating marginΒ -Β Metals Filtration (Before restructuring in 2007)

5%

3%

Operating margin -Β Microfiltration

16%

17%

Profit before tax growth

23%

10%

Earnings per share growth

21%

12%

Interest cover

7 times

8 times

Gearing

40%

20%

ROCE

8%

9%

The Group also considers progress towards commercialisation of its key growth projects to be a key indicator of performance. These indicators are discussed in detail throughout theΒ Chairman and Chief Executive's statementΒ and the Finance Director's review.

Impact of exchange rate movements on performance

Due to the international nature of the Group's businessΒ relative movements in exchange rates have an impact on the reported performance. Sterling weakened significantly against the US dollar and the Euro in the final quarter of theΒ year;Β however the GroupΒ had sold forward itsΒ 2008Β US dollar revenue generated by its UKΒ business at rates similar to those achieved in 2007 and the average rate used for translating the results of US operations into Sterling was less than 5% different from 2007. Consequently the Group's operating results for the year were not materially impacted by currency movements as compared with 2007.

Finance costs

Net interest payableΒ increasedΒ to Β£0.7mΒ (2007: Β£0.5m). InterestΒ paidΒ increased asΒ Group borrowings in the yearΒ roseΒ to fund capital expenditure and acquisitions,Β offset by some reduction in the effective interest rates. There wasΒ aΒ finance creditΒ in relation to the closed defined benefit pension schemeΒ of Β£0.1m (2007: Β£0.1m). Interest cover wasΒ 7Β times (2007: 8Β times).

Tax

The Group tax charge of Β£1.3m (2007: Β£1.0m)Β represents an effective tax rate ofΒ 31%Β (2007:Β 30%)Β on profits before tax. The tax charge comprises current tax of Β£0.8mΒ (2007: Β£0.5m)Β and a deferred tax charge of Β£0.5mΒ (2007: Β£0.5m). The Group carries a deferred tax asset in relation to theΒ pastΒ losses in itsΒ USΒ operationsΒ and the deficit on the pension fund. This tax assetΒ related to the past lossesΒ is limitedΒ toΒ the amount expected to be recovered in the foreseeable future.

Β Β Shareholders' funds

Shareholders' fundsΒ at 30 November 2008Β wereΒ Β£41.2mΒ (2007: Β£34.4m),Β an increase of 20% over the prior year. Shareholders' funds increased byΒ theΒ profit after tax of Β£2.9mΒ and a write back of Β£0.1m relating to share based payments;Β new shares issued on theΒ acquisition of SealΒ addedΒ Β£1.3m. Shareholders' funds wereΒ increasedΒ by exchangeΒ gainsΒ on retranslation of foreign currencies of Β£5.1m. Dividends paid of Β£0.9m andΒ actuarial losses net of deferred taxΒ of Β£1.7mΒ reduced shareholders funds.

Cash flow

Net cashΒ generatedΒ from operations was Β£4.2m (2007: Β£5.7m). Operating cash flow before working capital movements was Β£6.6mΒ (2007: Β£5.3m). Working capital outflowsΒ ofΒ Β£2.4mΒ (2007:Β inflow ofΒ Β£0.4m)Β principally comprise:Β increases in stock to serviceΒ 20% sales growth;Β the impact ofΒ higher raw material prices in MetalsΒ Filtration; a reduction of Seal's trade payables;Β and the impact ofΒ expenditure in 2008 of cash received in 2007 related to the new Microfiltration premises.Β Β 

Net interest paid wasΒ Β£0.7m (2007: Β£0.6m). The higherΒ interestΒ charge reflects the impact of increased borrowings to finance capital expenditure and acquisitions,Β offset by lower overall interest rates.

Tax paid of Β£0.6m (2007: Β£0.6m) was lower than the current tax charge as a result of repayments relating to prior periods.

CapitalΒ expenditureΒ increased to Β£3.5mΒ (2007: Β£2.0m).Β Β The main investments were: the fit outΒ of the new Microfiltration facility;Β additional manufacturing capacity installed in Metals FiltrationΒ forΒ new products; andΒ theΒ capitalisation ofΒ associatedΒ developmentΒ and project managementΒ costs.

Β£5.1m was paid to fundΒ acquisitions:Β Β£0.8mΒ relates to theΒ acquisition of Toolturn and Β£4.3m relates to the acquisition of Seal.

Borrowings and bank finance

At the year end, theΒ Group had net borrowings of Β£16.4m (2007: Β£7.0m) comprising gross borrowings of Β£18.9mΒ (2007: Β£9.9m)Β offset by cash balances ofΒ Β£2.5m (2007:Β Β£2.9m). Borrowings of Β£9.8m ($15.0m) are held in US dollars and the strengthening of the US dollar relative toΒ SterlingΒ increasedΒ the Group'sΒ net debtΒ by Β£2.4m compared with the prior year.

The Group put in place three yearΒ borrowing facilitiesΒ with Barclays BankΒ plcΒ in July 2008. At 30 November 2008 the Group had unutilised borrowing facilities of Β£1.3mΒ (2007: Β£1.4m),Β an unutilised overdraft facility of Β£1.5mΒ (2007: Β£3.0m)Β and cash balances of Β£2.5mΒ (2007: Β£2.9m).

The Group's gearing (net debt as a percentage of shareholders'Β funds) increased to 40% (2007: 20%).

Finance and treasury policy

The treasury function at Porvair is managed centrally, under Board supervision. It is not a profit centre and does not undertake speculative transactions. It seeks to limit the Group's exposure to trading in currencies other than its operations' local currency and to hedge its investments in currencies other thanΒ Sterling. The Group does not hedge against the impact of exchange rate movements on the translation of profits and losses of overseas operations.

At the year end,Β the Group had $15.0mΒ (2007: $14.8m)Β of US dollar borrowings exposure which hedged underlyingΒ USΒ net tangible assets on the balance sheet of $23.8mΒ (2007: $22.7m). In addition, the Group has a Euro 1.6m interest bearing debtor that was fully hedged by borrowings in Euros.

The Group finances its operations by a combination of share capital and retained profits;Β and short and long term loans. BorrowingsΒ throughout the year wereΒ principally at floating rate. Since the year end the Group has adopted a policy of fixing the interest rate on a portion of its borrowings.

Β Β Pension schemes

The Group continues to support itsΒ defined benefit pension scheme in theΒ UK, which is closed to new members,Β andΒ toΒ provide access to a defined contribution scheme for itsΒ USΒ employees and otherΒ UKΒ employees.Β 

The Group recorded a retirement benefit obligation of Β£3.7m (2007: Β£1.8m). The increase arose from an actuarial loss in the year of Β£2.2m and a current service cost of Β£0.3m offset by Β£0.5m of contributions and a Β£0.1m finance income credit.

DuringΒ 2007,Β a valuation of theΒ assets and liabilities of theΒ closed defined benefit schemeΒ was completed. As a result of this review,Β the Group and the Trustees agreed toΒ alterΒ the employer's contributions from 15% of salary to 8% of salaryΒ plus an Β£80,000 contribution towards the running costs of the scheme. The Group also committed to make additional annual contributions,Β to cover the past service deficit,Β of Β£250,000 per annum increasing by 5% per annum for the next eight years. The first payment was made in December 2007.

The next actuarial valuation of the scheme is due at 31 March 2009. It isΒ possibleΒ that the outcome of that valuation could requireΒ an increaseΒ in the contributions to cover the past service deficit. Any suchΒ increaseΒ would take effect in the 2010 or 2011 financial year.

Risks and uncertainties

There are a number of risks and uncertainties, described below,Β which could have a material impact on the Group's long term performance and prospects.

Existing market risk

The Group serves the needs of a range of specialist filtration markets, such that it is not dependent upon any one market. No single marketΒ represents more than 24%Β of sales.Β Β However, threeΒ keyΒ markets:Β aviation;Β aluminium filtration; and water analysisΒ eachΒ contribute more than 10% of the Group's revenue and the Group would be exposed to a significant decline in any of these segments.

The aerospace market has traditionally been a very steady business as the product cycles are very long and the Group offers a broad range of products,Β which are used both for new build and routine maintenance. The Board would expect to be able to manage the consequences of fluctuating aviation demand over time.

The productionΒ ratesΒ of aluminiumΒ can vary.Β Β Any impactΒ on the Group is dependent upon whetherΒ changes to productionΒ affect filtered or non-filtered aluminium.Β Β TheΒ Group has developed a new filter formulationΒ which has improved filtration and materials handling characteristics,Β which should improve its market positionΒ and is developing overseas markets for its aluminium cast shop business to enhance its offering.

Water analysis sales are generally made to laboratories engaged in meeting the regulatory requirements for clean water. As such,Β the market is expected to grow as water regulations tighten throughout the world and demand for clean water in the developing world increases. Whilst revenueΒ mightΒ be affected by access to capital in customer markets (municipal/utilityΒ and industrialΒ laboratories) it is expected that the regulated nature of this market will mitigate cyclical changes.

New products and markets risk

The GroupΒ has investedΒ significant amounts into the development of new products.Β Β Some of these new products are in theΒ early commercial or late development stages.Β Β There is a risk that theseΒ productsΒ may not be as commercially successful as expected.

The Group maintains a portfolio of potential products addressing different market segments and recognises that not all of its potential products will become significant revenue generators. The Group maintains a close review of each of its major developments and is not significantly exposed if the market for any one product does not develop.

Financing risk

The Group maintains a level of borrowing to finance its operations. Damage to, or loss of, its banking relationships could have a material impact on the Group. To mitigate this risk, the Group has sufficient long-term facilities in place for its expected requirements. It maintains a close relationship with its bankers and carefully monitors the restrictions on its borrowings.

Treasury and exchange rate risk

The Group has operations in theΒ UK,Β USΒ andΒ GermanyΒ and sells its products throughout the world. As a result, the Group is exposed to fluctuations in exchange rates. The Group maintains certain of its borrowings in US dollars to hedge its investments in theΒ USΒ and enters into forward sales of its principal foreign currency revenues to reduce the impact of exchange rate movements.

Liability risk

The Group manufactures products that are potentially vital to the safe operation of its customers' products or processes. A failure of theΒ Group'sΒ products could expose the Group to loss as a result of claims made by theΒ Group'sΒ customers or users of their products. TheΒ GroupΒ seeks to minimise this risk through limitations of liability in its contracts and carries insurance cover in the event that claims are made.

Competitive risk

Porvair operates in competitive global markets. The Group's achievement of its objectives is reliant on its ability to respond to many competitive factors including, but not limited to, pricing, technological innovations, product quality, customer service, manufacturing capabilities and the employment of qualified personnel. If the Group does not continue to compete in its markets effectively by developing innovative solutions for its customers, it could lose them and its results could be adversely affected.

Technological risk

Porvair has a broad portfolio of products delivered to a diverse range of markets. The Group's business could be affected if it does not:

continue to develop new designs for its customers that provide technical or cost advantages over its competitors;Β and
develop new technologies and materials that are adopted by its customers to provide improved performance.

The Group recognises that certain of its competitors are larger and have greater financial resources. This may enable them to deliver products on more attractive terms than the Group or to invest more resources, including research and development, than the Group.

The Group carefully selects its development prospects and monitors their progress carefully to maintain a range of potential opportunities. The nature of the Group's development projects means that their potential commercial or technical success cannot be assessed with certainty throughout the development process. The ultimate commercial success of a project can often only be judged when the development cycle is close to completion.

Raw materials,Β resources andΒ facilities risk

The Group uses raw materials in its production processes. Prices for these raw materials can be volatile and are affected by the cyclical movement in commodity prices such as oil,Β gas,Β alumina, silicon carbide and steel. The Group's ability to pass on these price fluctuations to its customers is to some extent dependent on the contracts it has entered into and the prevailing market conditions. There may be times when the Group's results are adversely affected by an inability to recover increases in raw material prices.Β 

The Group operates from a number of production facilities, the largest facility generating approximately one third of the Group's revenue. AΒ disaster, such as a fire or flood, at any of the Group's facilities could have a material impact on the Group's performance. The Group maintains insurance of its equipment and facilities and carries business interruption insurance to cover loss of profits. In addition, the Group has ISO 9001 and other industry specific quality control systems which reduce the risk that a disaster will occur.

Christopher Tyler

Group Finance Director

26 January 2009

Β Β 

Consolidated income statement

For the year ended 30 NovemberΒ 

Note

2008

2007

Continuing operations

Β£'000

Β£'000

Revenue

1

54,839

45,517

Cost of sales

(37,172)

(31,320)

Gross profit

17,667

14,197

Distribution costs

(705)

(679)

Administrative expenses

(12,146)

(9,683)

Operating profit

1

4,816

3,835

Interest payable and similar charges

(879)

(722)

Interest receivable

221

258

Profit before income tax

4,158

3,371

Income tax expense

(1,261)

(930)

Overseas taxΒ 

(27)

(65)

Profit for the year attributable to shareholders

2,870

2,376

Earnings per share (basic)

2

7.0p

5.8p

Earnings per share (diluted)

2

7.0p

5.8p

Consolidated statement of recognised income and expense

For the year ended 30 NovemberΒ 

2008

Β£'000

2007

Β£'000

Exchange differences on translation of foreign subsidiaries

5,119

(528)

ActuarialΒ (losses)/gains on defined benefit pension scheme

(2,200)

2,400

TaxationΒ credit/(charge)Β on items taken directly to equity

493

(756)

Net incomeΒ recognised directly in equity

3,412

1,116

Profit for the year

2,870

2,376

Total recognised income for the year attributable to shareholdersΒ 

6,282

3,492

Β Β 

ConsolidatedΒ balance sheet

As atΒ 30 November

2008

Β£'000

2007

Β£'000

Non-current assets

Property, plant and equipment

4

9,870

6,722

Goodwill and other intangible assets

4

38,604

27,138

Deferred tax asset

751

753

Other receivable

1,261

1,056

50,486

35,669

Current assets

Inventories

9,970

6,888

Trade and other receivables

11,078

7,888

Derivative financial instruments

-

44

Cash and cash equivalents

2,501

2,893

23,549

17,713

Current liabilities

Trade and other payables

(9,201)

(6,937)

Current tax liabilities

(372)

(224)

Bank overdraft and loans

(582)

(500)

Finance lease liabilities

(164)

-

Derivative financial instruments

(283)

-

Provisions for other liabilities and charges

-

(78)

(10,602)

(7,739)

Net current assets

12,947

9,974

Non-current liabilities

Bank loans

(18,316)

(9,364)

Finance lease liabilities

(169)

-

Retirement benefit obligations

(3,704)

(1,804)

Provisions for other liabilities and charges

5

(60)

(55)

(22,249)

(11,223)

Net assets

41,184

34,420

Capital and reserves

Share capital

6

841

814

Share premium account

6

34,024

32,765

Cumulative translation reserve

7

1,295

(3,824)

Retained earnings

7

5,024

4,665

Total shareholders' equity

41,184

34,420

Β Β ConsolidatedΒ cash flow statementΒ 

For the year ended 30 NovemberΒ 

Note

2008

Β£'000

2007

Β£'000

Cash flows from operating activities

Cash generated from operations

8

4,237

5,711

Interest received

91

130

Interest paid

(823)

(780)

Tax paid

(599)

(608)

Net cash generated from operating activities

2,906

4,453

Cash flows from investing activities

Acquisition of subsidiaries (net of cash acquired)

(5,121)

(1,046)

Purchase of property, plant and equipment

(2,628)

(1,688)

Purchase of intangible assets

(828)

(284)

Proceeds from sale of property, plant and equipment

7

295

Proceeds fromΒ sale of available for sale investments

-

200

Net cash used in investing activities

(8,570)

(2,523)

Cash flow from financing activities

Net proceeds from issue of ordinary share capital

-

153

Increase/(repayment) of borrowings

6,008

(68)

Dividends paid to shareholders

(909)

(853)

Capital element of finance leases

(88)

-

Net cashΒ generated from/(used in)Β financing activities

5,011

(768)

NetΒ (decrease)/increase in cash and cash equivalents

(653)

1,162

Effects of exchange rate changes

261

(25)

(392)

1,137

Cash and cash equivalents at 1 December

2,893

1,756

Cash and cash equivalents at 30 November

2,501

2,893

ReconciliationΒ of net cash flow to movement in net debt

2008

Β£'000

2007

Β£'000

NetΒ (decrease)/increase in cash and cash equivalents

(653)

1,162

Effects of exchange rate changes

(2,405)

238

(Increase)/repayment of borrowings

(6,368)

68

Net debt at 1 December

(6,971)

(8,439)

Net debt at 30 November

(16,397)

(6,971)

Β Β Notes

1. Segmental analyses

The segmental analyses of revenue, operating profit/(loss) and net assetsΒ and geographical analyses ofΒ revenueΒ are set out below:

PrimaryΒ reportingΒ formatΒ - business segments

2008

Metals Filtration

Microfiltration

Other Unallocated

Group

Β£'000

Β£'000

Β£'000

Β£'000

Revenue

22,498

32,341

-

54,839

Operating profit/(loss) before share based payments

1,061

5,101

(1,241)

4,921

Share based payments

-

(33)

(72)

(105)

Operating profit/(loss)

1,061

5,068

(1,313)

4,816

Finance costs

-

-

(658)

(658)

Profit/(loss) before income tax

1,061

5,068

(1,971)

4,158

Income tax expense

-

-

(1,288)

(1,288)

Profit/(loss) for the year

1,061

5,068

(3,259)

2,870

2007

Metals Filtration

Microfiltration

Other Unallocated

Group

Β£'000

Β£'000

Β£'000

Β£'000

Revenue

19,330

26,187

-

45,517

Operating profit/(loss) before share based payments

308

4,414

(783)

3,939

Share based payments

2

(31)

(75)

(104)

Operating profit/(loss)Β 

310

4,383

(858)

3,835

Finance costs

-

-

(464)

(464)

Profit/(loss) before income tax

310

4,383

(1,322)

3,371

Income tax expense

-

-

(995)

(995)

Profit/(loss) for the year

310

4,383

(2,317)

2,376

The "Other Unallocated"Β segment mainly comprises Group corporate costs, some research and development costs, new business development costs and general financial services.

In 2007, the Metals Filtration segment's operating profit for the yearΒ included aΒ restructuring charge of Β£0.2mΒ and theΒ Other Unallocated segment'sΒ operating lossΒ in 2007 includedΒ provisions written back of Β£0.4mΒ related to reduced expenses arising on the businesses disposedΒ ofΒ in 2003 and to the elimination of an onerous lease cost arising on a building that was refurbished and sublet in 2006 and disposed of in January 2008.Β 

Β Β 1. Segmental analyses continued

Net assets

At 30 November 2008

Metals Filtration

Microfiltration

Other Unallocated

Group

Β£'000

Β£'000

Β£'000

Β£'000

Segmental assets

29,737

39,781

755

70,273

Long term receivable

-

-

1,261

1,261

Cash and cash equivalents

-

-

2,501

2,501

Total assets

29,737

39,781

4,517

74,035

Segmental liabilities

(3,248)

(5,812)

(1,189)

(10,249)

Retirement obligations

-

-

(3,704)

(3,704)

Borrowings

-

-

(18,898)

(18,898)

Total liabilities

(3,248)

(5,812)

(23,791)

(32,851)

At 30 November 2007

Metals Filtration

Microfiltration

Other Unallocated

Group

Β£'000

Β£'000

Β£'000

Β£'000

Segmental assets

20,859

28,151

423

49,433

Long term receivable

-

-

1,056

1,056

Cash and cash equivalents

-

-

2,893

2,893

Total assets

20,859

28,151

4,372

53,382

Segmental liabilities

(1,847)

(4,587)

(860)

(7,294)

Retirement obligations

-

-

(1,804)

(1,804)

Borrowings

-

-

(9,864)

(9,864)

Total liabilities

(1,847)

(4,587)

(12,528)

(18,962)

Secondary reporting format - geographical segments

2008

2007

By destination

Β£'000

By origin

Β£'000

By destination

Β£'000

By origin

Β£'000

Revenue

United Kingdom

14,834

28,302

14,657

25,166

ContinentalΒ Europe

9,071

1,799

6,208

-

Americas

26,166

24,738

21,074

20,351

Asia

3,765

-

2,659

-

Australasia

490

-

457

-

Africa

513

-

462

-

54,839

54,839

45,517

45,517

Β Β 2. Earnings per share

2008

2007

Earnings

Β£'000

Weighted average number of shares

Per share amount (pence)

Earnings

Β£'000

Weighted average number of shares

Per share amount (pence)

Basic EPS - earnings attributable to ordinary shareholdersΒ 

2,870

41,041,288

7.0p

2,376

40,615,967

5.8p

Effect of dilutive securities - share options

-

17,817

-

-

125,036

-

Diluted EPS - adjusted earningsΒ 

2,870

41,059,105

7.0p

2,376

40,741,003

5.8p

3.Β  Dividends per share

2008

2007

Per share

Β£'000

Per share

Β£'000

Final dividend paid

1.20p

488

1.10p

446

Interim dividend paid

1.00p

421

1.00p

407

2.20p

909

2.10p

853

The Directors recommend theΒ payment of a final dividend of 1.25 penceΒ per shareΒ on 12Β June 2009 to shareholders on the register on 1 May 2009; the ex-dividend date is 29Β April 2009. This makes aΒ total dividend for the year of 2.25Β penceΒ per share (2007: 2.20Β pence per share).

4. Fixed assets

2008Β 

Property, plant and equipment

Goodwill

Other intangible assets

Total

Β£'000

Β£'000

Β£'000

Β£'000

Opening net book amount 1Β December 2007

6,722

26,512

626

33,860

Additions

2,628

-

828

3,456

Acquisitions (note 9)

553

5,673

519

6,745

Disposals

(8)

-

-

(8)

Depreciation, amortisationΒ andΒ impairment

(1,344)

-

(279)

(1,623)

Exchange differences

1,319

4,416

309

6,044

Closing net book amount 30 NovemberΒ 2008

9,870

36,601

2,003

48,474

2007Β 

Property, plant and equipment

Goodwill

Other intangible assets

Total

Β£'000

Β£'000

Β£'000

Β£'000

Opening net book amountΒ 1Β December 2006

6,596

26,243

475

33,314

Additions

1,688

-

284

1,972

Acquisitions

62

749

-

811

Disposals

(254)

-

-

(254)

Depreciation, amortisationΒ andΒ impairmentΒ 

(1,229)

-

(116)

(1,345)

Exchange differences

(141)

(480)

(17)

(638)

Closing net book amountΒ 30 NovemberΒ 2007

6,722

26,512

626

33,860

5. Provisions for other liabilities and charges

2008

Β£'000

2007

Β£'000

At 1 December

133

517

Charged to consolidated income statement:

Used during year

(78)

-

Additional provisions

-

55

Unused amounts reversed

-

(439)

Unwinding of discount

5

-

At 30 November

60

133

TheΒ Β£78,000Β utilised in 2008Β relates to a building sublet in 2006 andΒ surrenderedΒ in January 2008. The provision atΒ 30 NovemberΒ 2008 relates to a discounted dilapidations provision for leased property which is expectedΒ to be utilisedΒ in 2027. Details in relation to the reversal of provisions in 2007 are shown in Note 1.

6.Β  Share capital and premium

Number of sharesΒ 

Ordinary shares

Share premium account

Total

thousands

Β£'000

Β£'000

Β£'000

At 1 December 2006

40,575

811

32,615

33,426

Proceeds from the exercise of shares under share option schemes

124

3

150

153

AtΒ 30 November 2007

40,699

814

32,765

33,579

Issue of shares as consideration for the Seal Analytical acquisition

1,375

27

1,259

1,286

AtΒ 30 November 2008

42,074

841

34,024

34,865

7.Β  Other reserves

Cumulative translation reserve

Retained earnings

Β£'000

Β£'000

At 1 December 2006

(3,296)

1,394

Profit for the period attributable to shareholders

-

2,376

Direct to equity:

Dividends paid

-

(853)

Actuarial gains net of tax

-

1,680

Share based payments net of tax

-

68

Exchange differences

(528)

-

At 30Β NovemberΒ 2007

(3,824)

4,665

Profit for the period attributable to shareholders

-

2,870

Direct to equity:

Dividends paid

-

(909)

Actuarial losses net of tax

-

(1,652)

Share based payments net of tax

-

50

Exchange differences

5,119

-

AtΒ 30 NovemberΒ 2008

1,295

5,024

Β Β 8. Cash generated from operations

2008

Β£'000

2007

Β£'000

Operating profitΒ 

4,816

3,835

Non cash pension charge

100

100

Share based payments

105

104

Depreciation and amortisation

1,623

1,345

Loss/(profit)Β on disposal of property, plant and equipment

1

(41)

Operating cash flows before movement in working capital

6,645

5,343

Increase in inventories

(1,176)

(322)

DecreaseΒ in trade and other receivables

289

102

(Decrease)/increase/in payables

(1,443)

972

Decrease in provisions

(78)

(384)

(Increase)/decreaseΒ in working capital

(2,408)

368

Cash generated from operating activities

4,237

5,711

Acquisitions

Toolturn Engineering Limited

On 28 March 2008, The Group purchased 100% of the issued share capital of CM7 Limited and its wholly owned subsidiary Toolturn Engineering Limited for a total consideration of Β£990,000. The acquired business primarily sells to businesses within the Microfiltration segment and these transactions are eliminated on consolidation. The company contributed external revenues of Β£232,000Β and had a minimal impact on the Group's profitsΒ forΒ the period 29 March 2008 to 30Β NovemberΒ 2008. If the acquisition had occurred on 1 December 2007, the company would have contributed external revenues of Β£332,000 andΒ had a minimal impact on the Group's profits in the year ended 30 November 2008.

Note

Β£'000

Purchase consideration:

Cash paid

653

Deferred consideration

300

Direct costs relating to the acquisition

37

Total purchase consideration

990

Fair value of net assets acquired

(396)

Goodwill

4

594

The Goodwill is attributable to the workforce of the acquired business and synergies expected to arise after acquisition within the Microfiltration segment.

The total adjustments required to the book values of the assets and liabilities acquired in order to present the net assets at fair value in accordance with Group accounting policy were Β£4,000. The purchase has been accounted for as an acquisition.

The assets and liabilities as at 28Β March 2008 arising from the acquisition are as follows:

Fair value

Β£'000

Acquiree's carrying amount

Β£'000

Property, plant and equipment

444

444

Inventories

72

81

Trade and other receivables

373

365

Cash and cash equivalents

(106)

(106)

Trade and other payables

(195)

(191)

Deferred tax liabilities

(54)

(54)

Finance leases

(138)

(139)

Net assets acquired

396

400

Purchase consideration settled in cash

690

Cash and cash equivalents in assets acquired

106

Cash outflow on acquisition

796

The deferred consideration is represented byΒ interest bearingΒ loan notes issued totalling Β£300,000. The loan notes are repayable annually in equal instalments over a 3 year period.

Seal Analytical Limited

On 9 July 2008, the Group purchased 100% of the issued share capital of Seal Analytical LimitedΒ ('Seal'). The total consideration was Β£3,934,000. On acquisition, external loans included in the net liabilities acquiredΒ of Β£2,056,000 were repaid. SealΒ contributedΒ revenues ofΒ Β£3,198,000Β and a net profit of Β£130,000 to the Group in the period 9 July 2008 to 30 November 2008. If the acquisition had occurred on 1 December 2007, Seal would have contributedΒ revenues of Β£7,957,000 and a net profit of Β£293,000 to the Group in the year ended 30 November 2008.

Note

Β£'000

Purchase consideration:

Cash paid

2,274

Shares issued

1,286

Direct costs relating to the acquisition

374

Total purchase consideration

3,934

Fair value of net liabilities acquired

1,145

Goodwill

4

5,079

The fair value of the shares issued was based on the average published mid market price of the Porvair share price in the five business days prior to the acquisition.

The Goodwill is attributable to the workforce of the acquired business and synergiesΒ and potential for developmentΒ expected to arise after acquisition within the Microfiltration segment.

The total adjustments required to the book values of the assets and liabilities acquired in order to present the net assets at fair value in accordance with Group accounting policy were Β£495,000. The purchase has been accounted for as an acquisition.

The assets and liabilities as atΒ 9 JulyΒ 2008 arising from the acquisition are as follows:

Fair value

Β£'000

Acquiree's carrying amount

Β£'000

Property, plant and equipment

109

109

Software

487

348

Trademarks (included in intangibles)

32

-

Inventories

943

909

Trade and other receivables

1,767

1,482

Cash and cash equivalents

379

379

Trade and other payables

(2,536)

(2,541)

Borrowings

(2,116)

(2,116)

Finance leases

(272)

(272)

Corporation tax debtor

62

62

Net liabilitiesΒ acquired

(1,145)

(1,640)

Purchase consideration settled in cash

2,648

Cash and cash equivalents in assets acquired

(379)

Repayment of acquired borrowings

2,056

Cash outflow on acquisition

4,325

In 2007, the Group acquired the trade and assets of Omnifilter. The acquisition is disclosed in the annual financial statements for the year ended 30 November 2007.

10. Basis of preparationΒ 

The preliminary announcement forΒ the year ended 30 November 2008Β has been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union as at 30 November 2008. The financial information contained in this preliminary announcement does not constitute statutory accounts as defined in Section 240 of the Companies Act 1985. The financial information has been extracted from the financial statements forΒ the year ended 30 November 2008, which have been approved by the Board of Directors and on which the auditors have reported without qualification. The financial statements will be delivered to the Registrar of Companies after the Annual General Meeting. The financial statements forΒ the year ended 30 November 2007, upon which the auditors reported without qualification, have been delivered to the Registrar of Companies.

11. Annual general meeting

TheΒ Company's Annual General Meeting will be held onΒ Tuesday 7 April 2009Β atΒ 7 Regis Place, Bergen Way, King's Lynn, PE30 2JN.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FR BFMFTMMJTBLL
Date   Source Headline
5th Dec 20197:00 amRNSPre-close trading update
2nd Dec 201911:20 amRNSHolding(s) in Company
2nd Dec 201911:20 amRNSHolding(s) in Company
13th Nov 20192:51 pmRNSHolding(s) in Company
31st Oct 20197:00 amRNSTotal Voting Rights
8th Oct 201910:00 amRNSBlock listing update
20th Sep 201911:38 amRNSDirector/PDMR Shareholding
18th Sep 20197:00 amRNSNine months trading update
5th Sep 20197:00 amRNSAcquisition of Dahlman Industrial Group B.V.
28th Aug 201912:07 pmRNSSecond Price Monitoring Extn
28th Aug 201912:02 pmRNSPrice Monitoring Extension
23rd Aug 201912:07 pmRNSSecond Price Monitoring Extn
23rd Aug 201912:02 pmRNSPrice Monitoring Extension
6th Aug 201912:07 pmRNSSecond Price Monitoring Extn
6th Aug 201912:02 pmRNSPrice Monitoring Extension
28th Jun 201911:30 amRNSDirector/PDMR Shareholding
27th Jun 20194:35 pmRNSPrice Monitoring Extension
24th Jun 20197:00 amRNSHalf Year Results 2019
18th Jun 20197:00 amRNSBoard changes
6th Jun 20197:00 amRNSTrading Update
15th Apr 201912:30 pmRNSHolding(s) in Company
11th Apr 20193:13 pmRNSAGM resolutions
11th Apr 20197:00 amRNSAGM Trading Update
26th Mar 20194:35 pmRNSPrice Monitoring Extension
22nd Mar 201910:59 amRNSHolding(s) in Company
8th Mar 20191:33 pmRNSHolding(s) in Company
12th Feb 201912:02 pmRNSDirector/PDMR Shareholding
28th Jan 20197:00 amRNSResults for the year ended 30 November 2018
24th Dec 201812:40 pmRNSSecond Price Monitoring Extn
24th Dec 201812:35 pmRNSPrice Monitoring Extension
7th Dec 20187:00 amRNSPre-close trading update
21st Sep 20189:57 amRNSDirector/PDMR Shareholding
18th Sep 20187:00 amRNSNine months trading update
7th Sep 20184:40 pmRNSSecond Price Monitoring Extn
7th Sep 20184:35 pmRNSPrice Monitoring Extension
29th Aug 20185:06 pmRNSDirector Declaration
10th Aug 20183:00 pmRNSDirector's Shareholding
10th Jul 20183:22 pmRNSHolding(s) in Company
25th Jun 20187:00 amRNSHalf Yearly Results
6th Jun 20187:00 amRNSTrading Update
1st May 20189:50 amRNSHolding(s) in Company
18th Apr 20184:40 pmRNSSecond Price Monitoring Extn
18th Apr 20184:35 pmRNSPrice Monitoring Extension
17th Apr 20182:21 pmRNSAGM resolutions and Board changes
17th Apr 20187:00 amRNSAGM Trading Update
6th Apr 20184:40 pmRNSSecond Price Monitoring Extn
6th Apr 20184:35 pmRNSPrice Monitoring Extension
19th Mar 20186:16 pmRNSDirector's Shareholding
1st Mar 20187:00 amRNSAcquisition of Keystone Filter
14th Feb 201812:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.